BioLife Solutions, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period
BioLife Solutions, Inc. (BLFS) reported Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period of 181.27 thousand shares for the 12-month period ending 2018-12-31, per its 10-K filed 2019-03-15.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod · last filed 2019-03-15
- BioLife Solutions, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for the quarter ending 2018-12-31 was 0.00 shares.
- BioLife Solutions, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for the quarter ending 2018-09-30 was 7.50K shares.
- BioLife Solutions, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for the quarter ending 2018-06-30 was 12.00K shares.
- BioLife Solutions, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for the quarter ending 2018-03-31 was 161.77K shares.
- BioLife Solutions, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for fiscal 2018 was 181.27K shares, a 12.58% decline from fiscal 2017.
- BioLife Solutions, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for fiscal 2017 was 207.35K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 12 month |
|---|---|---|---|---|
| 2018-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-15 | 7.50K shares derived: sum of 2 quarters · filed 2019-03-15 | 19.50K shares derived: sum of 3 quarters · filed 2019-03-15 | 181.27K shares 10-K · filed 2019-03-15 |
| 2018-09-30 | 7.50K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | 19.50K shares derived: sum of 2 quarters · filed 2018-11-08 | 181.27K shares 10-Q · filed 2018-11-08 | |
| 2018-06-30 | 12.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | 173.77K shares 10-Q · filed 2018-08-09 | ||
| 2018-03-31 | 161.77K shares 10-Q · filed 2018-05-11 | |||
| 2017-12-31 | 207.35K shares 10-K · filed 2019-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B |